KENYA – Pharmaceutical Society of Kenya (PSK) has appointed four new executives to strengthen its management team, maintain a standard for professional conduct and code ethics for its members as well as advance the practice of Pharmacy.

Established in 1964, Pharmaceutical Society of Kenya is a representative organization that was formed to enable Pharmacists’ employ their professional expertise in the care of patients, promote a common standard for professional conduct and code of ethics, as well as advocate the welfare Pharmacists.

The organization is mandated to enhance the quality of Pharmacy practice and keep members up-to-date with changes in Pharmacy practice, the law relating to Pharmacy and the latest technology applicable to Pharmacy.

The Pharmaceutical Society of Kenya has appointed Dr Lucas Kimanga Nyabero as the new Chief Executive Officer, Dr Joseph Kathare as Vice President Practice, Dr Daniella Munene as Vice President Governance and Dr Tabitha Wambui Kimani as Vice President Lobbying to join the society’s leadership.

The new Chief Executive Officer Dr Lucas Kimanga Nyabero brings to the table an extensive experience in the field of Pharmacy practice as a certified pharmacogenomics pharmacist, certified immunization pharmacist and certified in delivering medication therapy management services.

Dr Lucas Nyabero previously served as a clinical pharmacist and community pharmacist as well as co-founded a Silicon Valley healthcare technology company. He also has a patent on a neuropathic pain product with experience leading a preventive healthcare company.

At the same time, the new Vice President Practice Dr Joseph Kathare is a registered pharmacist who specializes in Medication Therapy management with plans on bettering PSK operations. He has an ongoing research in the area of Pharmacology and Toxicology dedicated to the evolvement of pharmaceutical practice.

Dr Joseph Kathare has a Bachelors Degree in Pharmacy from Kampala International University, Masters of Science degree in Pharmacology and Toxicology from the University of Nairobi and is currently enrolled at the University of Maricon in Italy for an Executive MBA in Leadership.

Vice President Dr Daniella Munene expertise includes strategic planning, business development, team leadership and management of key stakeholder relationships in health while Vice President Dr Tabitha Kimani has worked as medication safety pharmacist, Medical Officer of Health and Medical Superintendent.

Moreover, the recent executive appointments will support the PSK in advocating for appropriate pharmaceutical policies along with participating in implementation of pharmaceutical policies through appropriate review of existing pharmacy regulations and laws with the aim of protecting public interest.

Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE